142 related articles for article (PubMed ID: 36892444)
1. Oral cancers preceded by proliferative verrucous leukoplakia exhibit distinctive molecular features.
Herreros-Pomares A; Hervás D; Bagan-Debon L; Proaño A; Garcia D; Sandoval J; Bagan J
Oral Dis; 2024 Apr; 30(3):1072-1083. PubMed ID: 36892444
[TBL] [Abstract][Full Text] [Related]
2. Differentially methylated genes in proliferative verrucous leukoplakia reveal potential malignant biomarkers for oral squamous cell carcinoma.
Herreros-Pomares A; Llorens C; Soriano B; Bagan L; Moreno A; Calabuig-Fariñas S; Jantus-Lewintre E; Bagan J
Oral Oncol; 2021 May; 116():105191. PubMed ID: 33657465
[TBL] [Abstract][Full Text] [Related]
3. Whole genome DNA methylation and mutational profiles identify novel changes in proliferative verrucous leukoplakia.
Okoturo E; Green D; Clarke K; Liloglou T; Boyd MT; Shaw RJ; Risk JM
Oral Surg Oral Med Oral Pathol Oral Radiol; 2023 Jun; 135(6):893-903. PubMed ID: 37088660
[TBL] [Abstract][Full Text] [Related]
4. CpG location and methylation level are crucial factors for the early detection of oral squamous cell carcinoma in brushing samples using bisulfite sequencing of a 13-gene panel.
Morandi L; Gissi D; Tarsitano A; Asioli S; Gabusi A; Marchetti C; Montebugnoli L; Foschini MP
Clin Epigenetics; 2017; 9():85. PubMed ID: 28814981
[TBL] [Abstract][Full Text] [Related]
5. Global gene expression profile of proliferative verrucous leukoplakia and its underlying biological disease mechanisms.
Farah CS; Shearston K; Turner EC; Vacher M; Fox SA
Oral Oncol; 2024 Apr; 151():106737. PubMed ID: 38408418
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India.
Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R
Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608
[TBL] [Abstract][Full Text] [Related]
7. [Comparative analysis of methylation profiles in tissues of oral leukoplakia and oral squamous cell carcinoma].
Fu J; Su Y; Liu Y; Zhang XY
Zhonghua Kou Qiang Yi Xue Za Zhi; 2018 Apr; 53(4):248-253. PubMed ID: 29690695
[No Abstract] [Full Text] [Related]
8. [The p16 methylation in oral leukoplakia and oral squamous cell carcinoma].
Liu HW; Hu BQ; Cao CF
Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 Mar; 40(2):94-7. PubMed ID: 15842853
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide DNA methylation profiling of HPV-negative leukoplakia and gingivobuccal complex cancers.
Inchanalkar M; Srivatsa S; Ambatipudi S; Bhosale PG; Patil A; Schäffer AA; Beerenwinkel N; Mahimkar MB
Clin Epigenetics; 2023 May; 15(1):93. PubMed ID: 37245006
[TBL] [Abstract][Full Text] [Related]
10. Malignant transformation of proliferative verrucous leukoplakia to oral squamous cell carcinoma: a series of 55 cases.
Bagan JV; Jiménez-Soriano Y; Diaz-Fernandez JM; Murillo-Cortés J; Sanchis-Bielsa JM; Poveda-Roda R; Bagan L
Oral Oncol; 2011 Aug; 47(8):732-5. PubMed ID: 21683646
[TBL] [Abstract][Full Text] [Related]
11. The methylation status and expression of human telomerase reverse transcriptase is significantly high in oral carcinogenesis.
Haraguchi K; Yada N; Sato S; Habu M; Hayakawa M; Takahashi O; Sasaguri M; Takenaka S; Yoshioka I; Matsuo K; Tominaga K
APMIS; 2017 Sep; 125(9):797-807. PubMed ID: 28766760
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation profiling revealed promoter hypermethylation-induced silencing of p16, DDAH2 and DUSP1 in primary oral squamous cell carcinoma.
Khor GH; Froemming GR; Zain RB; Abraham MT; Omar E; Tan SK; Tan AC; Vincent-Chong VK; Thong KL
Int J Med Sci; 2013; 10(12):1727-39. PubMed ID: 24155659
[TBL] [Abstract][Full Text] [Related]
13. Aberrantly hypermethylated tumor suppressor genes were identified in oral squamous cell carcinoma (OSCC).
Kim SY; Han YK; Song JM; Lee CH; Kang K; Yi JM; Park HR
Clin Epigenetics; 2019 Aug; 11(1):116. PubMed ID: 31405379
[TBL] [Abstract][Full Text] [Related]
14. An integrated methylation and gene expression microarray analysis reveals significant prognostic biomarkers in oral squamous cell carcinoma.
Zhao C; Zou H; Zhang J; Wang J; Liu H
Oncol Rep; 2018 Nov; 40(5):2637-2647. PubMed ID: 30226546
[TBL] [Abstract][Full Text] [Related]
15. Proliferative verrucous leukoplakia: high incidence of gingival squamous cell carcinoma.
Bagan JV; Jimenez Y; Sanchis JM; Poveda R; Milian MA; Murillo J; Scully C
J Oral Pathol Med; 2003 Aug; 32(7):379-82. PubMed ID: 12846783
[TBL] [Abstract][Full Text] [Related]
16. Proliferative verrucous leukoplakia: unusual locations of oral squamous cell carcinomas, and field cancerization as shown by the appearance of multiple OSCCs.
Bagán JV; Murillo J; Poveda R; Gavaldá C; Jiménez Y; Scully C
Oral Oncol; 2004 Apr; 40(4):440-3. PubMed ID: 14969824
[TBL] [Abstract][Full Text] [Related]
17. Immune expression profile identification in a group of proliferative verrucous leukoplakia patients: a pre-cancer niche for oral squamous cell carcinoma development.
Llorens C; Soriano B; Trilla-Fuertes L; Bagan L; Ramos-Ruiz R; Gamez-Pozo A; Peña C; Bagan JV
Clin Oral Investig; 2021 May; 25(5):2645-2657. PubMed ID: 32918120
[TBL] [Abstract][Full Text] [Related]
18. On the Oral Microbiome of Oral Potentially Malignant and Malignant Disorders: Dysbiosis, Loss of Diversity, and Pathogens Enrichment.
Herreros-Pomares A; Hervás D; Bagan-Debón L; Jantus-Lewintre E; Gimeno-Cardona C; Bagan J
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834903
[TBL] [Abstract][Full Text] [Related]
19. Molecular landscape of proliferative verrucous leukoplakia: a systematic review.
Nissanka-Jayasuriya EH; Fenton TR; Rose-Zerilli MJJ
Br J Oral Maxillofac Surg; 2024 Feb; 62(2):118-127. PubMed ID: 38296711
[TBL] [Abstract][Full Text] [Related]
20. High-risk oral leukoplakia is associated with aberrant promoter methylation of multiple genes.
Abe M; Yamashita S; Mori Y; Abe T; Saijo H; Hoshi K; Ushijima T; Takato T
BMC Cancer; 2016 Jun; 16():350. PubMed ID: 27255271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
